Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha vs Allogeneic BMT in CML
NCT00002771Phase 3Unknown
- Sponsor
- German CML Study Group
- Start
- Jan 1995
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa in chronic myeloid leukemia (CML), sponsored by German CML Study Group. Status: unknown.
02
Drugs
interferon alfa
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00002771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002771.